ATAGI advises GPs not to administer AstraZeneca vaccine to under-60s
The decision to raise the age threshold from 50 follows 12 new cases of thrombosis with thrombocytopenia syndrome
GPs have been advised not to administer AstraZeneca’s COVID-19 vaccine to patients aged under 60 because of the risks of thrombosis with thrombocytopenia syndrome.
The decision to raise the recommended age threshold from 50 was announced by the Australian Technical Advisory Group on Immunisation (ATAGI) on Thursday morning and means another major shake-up for the 4300 GP practices taking part in the vaccine rollout.
The advice, endorsed by the Federal Government, follows 12 new cases of the thrombosis with thrombocytopenia syndrome (TTS) over the last week.
According to the TGA, seven were in patients aged 50-59.
